Fulcrum Therapeutics is hosting a bipartisan briefing bringing together Members of Congress, clinical experts, patient advocates, and policy leaders to discuss opportunities to expand access to innovative therapies and strengthen outcomes for individuals and families affected by SCD.
The briefing will take place at the Rayburn House Office Building, Room 2043, Washington, DC.















































































































































































































































































